Insider and congress filings
Bristol-Myers Squibb Company (BMY)
About Bristol-Myers Squibb Company
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Christopher Boerner
- Employees
- 32,500
- Listed since
- -
- Market value
- $131.6B
- Price to earnings
- 14.2
- Earnings per share
- $4.55
- Dividend yield
- 3.90%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $2.04 | $1.60 | $13.0B | $11.7B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $1.58 | $1.42 | $11.5B | $10.9B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 5, 2026 | $1.26 | $1.23 | $12.5B | $12.3B | EPS beatRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $1.63 | $1.52 | $12.2B | $11.9B | EPS beatRevenue beat |
| Q2 FY2025reported Jul 31, 2025 | $1.46 | $1.09 | $12.3B | $11.4B | EPS beatRevenue beat |
| Q1 FY2025reported Apr 24, 2025 | $1.80 | $1.49 | $11.2B | $10.7B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 25, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Christopher S. BoernerPh.D. Board Chair and Chief Executive Officer | $1.6M | $16.1M | $4.2M | $21.9M |
| Cristian Massacesi , M.D.EVP, Chief Medical Officer, Head of Development | $388K | $7.9M | $1.8M | $10.1M |
| Adam LenkowskyEVP, Chief Commercialization Officer | $1.1M | $6.1M | $2.1M | $9.3M |
| David V. ElkinsEVP and Chief Financial Officer | $1.1M | $6.0M | $2.1M | $9.2M |
| Greg MeyersEVP, Chief Digital and Technology Officer | $1.1M | $4.2M | $1.9M | $7.2M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $10.4B | 180,384,994 | +5.1% | 8.83% |
| Vanguard Capital Management LLC | $7.7B | 133,337,856 | +0.8% | 6.53% |
| State Street Corp | $5.9B | 102,408,940 | +3.9% | 5.02% |
| Jpmorgan Chase & Co | $4.2B | 71,713,442 | -22.5% | 3.51% |
| Charles Schwab Investment Management Inc | $3.9B | 67,595,177 | +10.6% | 3.31% |
| Sixth Street Partners Management Company, L.P. | $3.9B | 67,595,177 | +100.0% | 3.31% |
| Geode Capital Management, LLC | $3.2B | 56,443,077 | +2.1% | 2.76% |
| Vanguard Portfolio Management LLC | $2.7B | 46,873,015 | +1.4% | 2.30% |
| Norges Bank | $2.1B | 36,866,658 | +100.0% | 1.81% |
| Bank Of America Corp | $2.0B | 34,045,352 | +4.5% | 1.67% |
| Price T Rowe Associates Inc | $1.8B | 31,707,643 | +209.3% | 1.55% |
| Morgan Stanley | $1.7B | 29,009,025 | -0.6% | 1.42% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
2 filings of 329 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Phil M. HolzerSVP and Controller | Sold | 500 | $67.50 | $34K | Aug 25, 2026 | 1d |
| David V. ElkinsEVP, Chief Financial Officer | Sold · 2 lines | 30,000 | $61.67 | $1.9M | Apr 1, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in BMY
20 disclosures of 165 on record · median 28d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +10.0%S&P +20.2% · vs S&P 500 -10.2% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +15.2%S&P +1.6% · vs S&P 500 +13.6% | Jun 16, 2026 | Jul 6, 2026 | 20d |
| Mike KellySpouse | Stock | Sale | $15,001 - $50,000 | +14.5%S&P +4.2% · vs S&P 500 +10.3% | May 7, 2026 | Jun 11, 2026 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +13.0%S&P +3.2% · vs S&P 500 +9.9% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +10.9%S&P +11.1% · vs S&P 500 -0.2% | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +8.7%S&P +13.0% · vs S&P 500 -4.3% | Feb 5, 2026 | Mar 9, 2026 | 32d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +18.7%S&P +9.8% · vs S&P 500 +8.9% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +18.4%S&P +11.1% · vs S&P 500 +7.3% | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +20.8%S&P +12.7% · vs S&P 500 +8.1% | Dec 18, 2025 | Jan 15, 2026 | 28d |
| Julia LetlowFiled late | Stock | Purchase | $1,001 - $15,000 | +21.4%S&P +32.1% · vs S&P 500 -10.7% | Oct 23, 2024 | Jan 13, 2026 | 447d |
| Julia LetlowFiled late | Stock | Sale | $1,001 - $15,000 | +32.9%S&P +38.6% · vs S&P 500 -5.7% | Apr 28, 2025 | Jan 13, 2026 | 260d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +18.9%S&P +11.7% · vs S&P 500 +7.2% | Dec 19, 2025 | Jan 12, 2026 | 24d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +31.2%S&P +11.6% · vs S&P 500 +19.7% | Nov 12, 2025 | Dec 15, 2025 | 33d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +32.5%S&P +13.4% · vs S&P 500 +19.0% | Nov 13, 2025 | Dec 11, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +40.0%S&P +11.6% · vs S&P 500 +28.4% | Nov 3, 2025 | Dec 8, 2025 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +44.2%S&P +13.6% · vs S&P 500 +30.6% | Oct 9, 2025 | Nov 18, 2025 | 40d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +45.9%S&P +14.9% · vs S&P 500 +31.0% | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +36.6%S&P +17.8% · vs S&P 500 +18.8% | Sep 5, 2025 | Oct 3, 2025 | 28d |
| Val T. HoyleSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +22.7%S&P +31.1% · vs S&P 500 -8.4% | Oct 29, 2024 | Sep 12, 2025 | 318d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +34.7%S&P +18.2% · vs S&P 500 +16.5% | Aug 14, 2025 | Sep 11, 2025 | 28d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
7 members · estimate, as of Sep 10, 20267 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gerald E. Connolly | Democrat · House | $50,001 - $100,000 | 9.6% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Gary C. Peters | Democrat · Senate | $15,001 - $50,000 | 1.0% |
| Andrew R. Garbarino | Republican · House | $1,001 - $15,000 | 40.5% |
| Cliff Bentz | Republican · House | $1,001 - $15,000 | 0.6% |
| Sam Liccardo | Democrat · House | $1,001 - $15,000 | 1.2% |
| Mike Kelly | Republican · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Bartie Wendy ShortEVP, Corporate Affairs | Tax withholding | 633 | Sep 1, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Option exercise | 1,236 | Sep 1, 2026 |
| Cristian MassacesiEvp,chief Med Offr,head of Dev | Option exercise | 51,172 | Aug 1, 2026 |
| Cari GallmanEVP, General Counsel | Option exercise | 1,061 | Aug 1, 2026 |
| Cari GallmanEVP, General Counsel | Tax withholding | 543 | Aug 1, 2026 |
| Cristian MassacesiEvp,chief Med Offr,head of Dev | Tax withholding | 26,175 | Aug 1, 2026 |
| Phyllis R. YaleDirector | Stock award | 1,215 | Jun 30, 2026 |
| Theodore R. Samuels IIDirector | Stock award | 1,779 | Jun 30, 2026 |
| Derica W. RiceDirector | Stock award | 1,345 | Jun 30, 2026 |
| Michael R. McMullenDirector | Stock award | 1,215 | Jun 30, 2026 |
| Peter J. ArduiniDirector | Stock award | 1,215 | Jun 30, 2026 |
| Julia A. HallerDirector | Option exercise | 20,460 | Jun 15, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Tax withholding | 3,876 | Jun 3, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Option exercise | 8,040 | Jun 3, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Tax withholding | 599 | May 1, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Option exercise | 1,373 | May 1, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Other (see filing) | 203 | May 1, 2026 |
| Phyllis R. YaleDirector | Stock award | 1,154 | Mar 31, 2026 |
| Peter J. ArduiniDirector | Stock award | 1,154 | Mar 31, 2026 |
| Theodore R. Samuels IIDirector | Stock award | 1,690 | Mar 31, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling BMY?
Across the 2 most recent open-market filings shown here, 0 were purchases and 2 were sales.
Which members of Congress have traded BMY?
Alan Armstrong, Ro Khanna, Mike Kelly, Julie Johnson, Julia Letlow, Gilbert Ray Cisneros, Jr. and others disclosed BMY transactions in the filings shown here.
Which members of Congress hold BMY?
7 members of Congress report a position in BMY in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Gerald E. Connolly, Gilbert Ray Cisneros, Jr. and Gary C. Peters. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is BMY in the S&P 500 or the Nasdaq 100?
Bristol-Myers Squibb Company is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are BMY trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.